Genelux (GNLX) Free Cash Flow (2022 - 2026)
Genelux (GNLX) recorded quarterly Free Cash Flow of -$7.0 million in Q1 2026, down 5.18% quarter-over-quarter from -$6.6 million in Q4 2025, and down 27.72% on a YoY basis from -$9.7 million in Q1 2025.
Genelux (GNLX) Free Cash Flow (2022 - 2026) Analysis & Trends
Genelux's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$7.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 27.72% year-over-year to -$7.0 million; the TTM figure through Mar 2026 stood at -$27.9 million (down 23.02% YoY), while the FY2025 annual figure was -$26.4 million, down 22.16% from the prior year.
- Free Cash Flow was -$7.0 million for Q1 2026 at Genelux, down from -$6.6 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $2.8 million in Q1 2022 to a low of -$7.2 million in Q2 2025.
- Historically, Free Cash Flow has averaged -$5.0 million across 5 years, with a median of -$5.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow plunged 371.21% in 2023, then surged 38.52% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$1.5 million in 2022, then slumped by 371.21% to -$7.2 million in 2023, then soared by 38.52% to -$4.4 million in 2024, then plunged by 50.89% to -$6.6 million in 2025, then declined by 5.18% to -$7.0 million in 2026.
- The last three Free Cash Flow figures came in at -$7.0 million (Q1 2026), -$6.6 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -6.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.98 Mn |
| Mar 31, 2026 | -6.98 Mn |
| Dec 31, 2025 | -6.64 Mn |
| Dec 31, 2025 | -6.64 Mn |
| Sep 30, 2025 | -7.12 Mn |
| Sep 30, 2025 | -7.12 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Mar 31, 2025 | -5.47 Mn |
| Mar 31, 2025 | -5.47 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Dec 31, 2023 | -7.15 Mn |
| Dec 31, 2023 | -7.15 Mn |